S&P 500   2,994.81 (+0.17%)
DOW   26,998.27 (-0.01%)
QQQ   193.08 (+0.02%)
AAPL   233.64 (-0.31%)
FB   189.54 (+-0.01%)
MSFT   139.13 (-0.91%)
GOOGL   1,252.26 (+0.74%)
AMZN   1,788.00 (+0.59%)
NVDA   192.88 (-0.68%)
MU   45.39 (+0.51%)
BABA   176.34 (-0.44%)
GE   9.08 (+2.02%)
AMD   30.95 (+0.45%)
T   37.67 (-0.32%)
NFLX   296.75 (+3.66%)
BAC   30.13 (-0.13%)
S&P 500   2,994.81 (+0.17%)
DOW   26,998.27 (-0.01%)
QQQ   193.08 (+0.02%)
AAPL   233.64 (-0.31%)
FB   189.54 (+-0.01%)
MSFT   139.13 (-0.91%)
GOOGL   1,252.26 (+0.74%)
AMZN   1,788.00 (+0.59%)
NVDA   192.88 (-0.68%)
MU   45.39 (+0.51%)
BABA   176.34 (-0.44%)
GE   9.08 (+2.02%)
AMD   30.95 (+0.45%)
T   37.67 (-0.32%)
NFLX   296.75 (+3.66%)
BAC   30.13 (-0.13%)
Log in

Motif Bio Stock Price, News & Analysis (LON:MTFB)

GBX 0.69
+0.01 (+1.47 %)
(As of 10/17/2019 12:05 PM ET)
Today's Range
0.55
Now: GBX 0.69
0.79
50-Day Range
0.60
MA: GBX 1.88
2.75
52-Week Range
0.45
Now: GBX 0.69
44.90
Volume7.40 million shs
Average Volume400,302 shs
Market Capitalization£2.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone609-608-0032

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowGBX 0.52 per share
Book ValueGBX (3.20) per share

Profitability

Miscellaneous

Employees8
Market Cap£2.36 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MTFB News and Ratings via Email

Sign-up to receive the latest news and ratings for MTFB and its competitors with MarketBeat's FREE daily newsletter.


Motif Bio (LON:MTFB) Frequently Asked Questions

What is Motif Bio's stock symbol?

Motif Bio trades on the London Stock Exchange (LON) under the ticker symbol "MTFB."

What is the consensus analysts' recommendation for Motif Bio?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motif Bio in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motif Bio.

Has Motif Bio been receiving favorable news coverage?

News stories about MTFB stock have been trending very negative recently, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Motif Bio earned a news sentiment score of -3.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Motif Bio.

Who are some of Motif Bio's key competitors?

What other stocks do shareholders of Motif Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Motif Bio investors own include Hawkins (HWKN), Sirius Minerals (SXX), CA (CA), Egdon Resources (EDR), Endologix (ELGX), BlackRock (BLK), Global Blood Therapeutics (GBT), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH) and Aegean Marine Petroleum Network (ANW).

Who are Motif Bio's key executives?

Motif Bio's management team includes the folowing people:
  • Mr. Graham George Lumsden, CEO & Exec. Director (Age 59)
  • Mr. Jonathan E. Gold, CFO & Exec. Director (Age 46)
  • Dr. David B. Huang, Chief Medical Officer (Age 44)
  • Mr. Robert Dickey IV, Advisor (Age 63)
  • Laurie Doyle, Head of Investor Relations & Corp. Communications

How do I buy shares of Motif Bio?

Shares of MTFB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Motif Bio's stock price today?

One share of MTFB stock can currently be purchased for approximately GBX 0.69.

How big of a company is Motif Bio?

Motif Bio has a market capitalization of £2.36 million. Motif Bio employs 8 workers across the globe.View Additional Information About Motif Bio.

What is Motif Bio's official website?

The official website for Motif Bio is http://www.motifbio.com/.

How can I contact Motif Bio?

Motif Bio's mailing address is One Tudor Street, LONDON, EC4Y 0AH, United Kingdom. The company can be reached via phone at 609-608-0032.


MarketBeat Community Rating for Motif Bio (LON MTFB)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  345 (Vote Outperform)
Underperform Votes:  244 (Vote Underperform)
Total Votes:  589
MarketBeat's community ratings are surveys of what our community members think about Motif Bio and other stocks. Vote "Outperform" if you believe MTFB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTFB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel